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aBSTRaCT
In this article, we report the molecular characterization of extensively drug resistant (XDr), extended 
spectrum, class C beta-lactamases and NDM-1 carbapenemase producing E. coli, isolated from the scrotal 
fluid of a 3-year-old male dog. In an antibiotic susceptibility test the E. coli isolate was susceptible only to 
tigecycline and resistant to all clinically applicable antibiotics tested in the study. the minimum inhibitory 
concentration (MIC) of meropenem, cefotaxime and cefepime was 256, 128 and 64 µg/mL, respectively. On 
genotypic screening by PCr, the isolate was positive for blaNDM, blaCtX-M, blaampC, blateM and sul1 
genes. the isolate was a eSBL, ampC and metalo beta-lactamase producer. On molecular pathotyping, the 
isolate harbored the Shiga toxin producing gene (Stx2). the extensively drug resistant, carbapenem resistant and 
eSBL producing E. coli constitutes a major public health concern, since there is a great chance of dissemination 
of resistance genes to humans due to the close association of humans and companion animals. to the best of our 
knowledge, this is the first report of blaNDM1 isolated from a dog in India. 
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introduction 
Nowadays keeping companion animals, especially dogs and cats, is gaining popularity 
due to the changes in lifestyle of human beings and also the growing attention given to 
pet care. as a result of increased pet care, antimicrobial agents are commonly used in 
companion animal practice, often including antimicrobial preparations used in human 
medicine. at present, antimicrobial drug resistance is a problem all over the world. the 
blanket use of antimicrobials has led to the emergence and spread of antimicrobial drug 
resistance in microbes, including pathogens, leading to imbalance in the microbiota of 
our systems and environment. the occurrence of antimicrobial resistant strains in food 
producing and companion animals is increasing and leading to alarm that the cross 
species spread of these resistant bacteria could be of great public health significance 
(StOLLe et al., 2013; Ghatak et al., 2013; PrUthVIShree et al., 2017). the term 
“extensive drug resistance” (XDr) is used to signify gram negative bacteria resistant to 
all potentially effective antibiotics, except one to two antibiotics left as treatment options 
(FaLaGaS and karaGeOrGOPOULOS, 2008). the antibacterial resistant bacteria 
harboring virulence markers are hazardous, since they cause infections which are difficult 
to treat. Shiga toxin (SetC) producing E. coli is of public health concern, and animals 
may be reservoirs, and they produce two potent cytotoxins (Stx1, Stx2), which inhibit 
protein synthesis (BeNtaNCOr et al., 2012). 
rising numbers of carbapenem resistant and eSBL‐producing E. coli in food‐
producing and companion animals (CarattOLI, 2008; SMet et al., 2010; Ghatak 
et al., 2013; PrUthVIShree et al., 2017) may spread into the environment and also 
to humans. Companion animals have become more similar to family members and they 
share intimate contact with their owners, which can result in transmission cycles of multi‐
drug resistant bacteria (MDr), as it is known that the microbiota of pets and their owners 
can be very similar (eWerS et al., 2011; WaLther et al., 2012; JOhNSON et al., 
2008). Increasing infections with antibacterial resistant bacteria are also accompanied by 
a decrease in the efficacy of treatment (ALANIS, 2005; STOYCHEVA and MURDJEVA, 
2006; WALSH and FANNING, 2008; AJIBOYE et al., 2009). The present study reports 
the molecular characterization of a XDr E. coli harboring blaNDM1 gene. 
Materials and methods
Sample collection and Isolation of E. coli. a male Labrador dog aged 3 years 
was presented to the referral veterinary hospital, Indian Veterinary research Institute, 
Izatnagar, Bareilly, India with loss of appetite, scrotal edema and fever. The scrotal fluid 
was collected aseptically and processed for bacteriological analysis and biochemical 
characterization (QUINN et al., 1994).
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Phenotypic screening for carbapenem resistance and metallo betalactamase and 
extended spectrum and class C beta-lactamase production. the strains (accession No: 
kt853018, kr296661, kX090926 and kt593874) were collected from the repository 
maintained by the Division of epidemiology, Indian Veterinary research Institute, 
Izatnagar, to serve as reference strains. The biochemically confirmed E. coli isolate was 
screened for antibiotic susceptibility patterns with amikacin (30 µg), amoxicillin (10 μg), 
amoxicillin/clavulanic acid (20/10 μg), aztreonam (30 μg), cefoxitin (30 μg), cefixime (5 
μg), cefpodoxime (10 μg), cefotaxime/clavulanic acid (30/10 μg), cephalexine (30 μg), 
ceftrioxone (30 μg), ceftazidime (30 μg) ceftazidime/clavulanic acid (30/10 μg), cefipime 
(30 μg ), cefadroxil, (30 μg), ceftriaxone (30 µg), cefotaxime (30 μg), cefoperazone 
(75 µg), cefepime-tazobactam (80/10 µg), colisitin (10 μg ), chloramphenicol (30 µg), 
ciprofloxacin (5 µg), co-trimoxazole (1.25/23.75 µg), ertapenem (10 μg), fosfomycin 
(200 µg), gatifloxacin (5 µg), imipenem (10 μg), meropenem (10 μg), pipercillin (100 μg), 
tetracycline (30 μg), nitrofurantoin (300 μg), gentamicin (10 μg), triple sulpha(0.25 μg), 
ofloxacin (5 µg), norfloxacin (10 µg), piperacillin-tazobactam (100/10 µg), polymyxin B 
(300 U), tobramycin (10 µg), vancomycin (5 µg), tigecycline (15 µg),) and moxalactam 
(30 µg). the Clinical and Laboratory Standard Institute (CLSI, 2015) breakpoints were 
used for inference of antibacterial susceptibility pattern. 
the isolate was also assayed for carbapenem susceptibility and eSBL production. 
Metallo beta-lactamase production (MBL) detection was performed using meropenem 
(10 µg), imipenem (10 µg) and ertapenem (10 µg) along with metal ion chelator ethylene 
diamine tetra acetic acid (eDta) (1900 mg) disks for the Double disk synergy test (DDSt) 
as mentioned by GaLaNI et al. (2008). a keyhole reaction, i.e. any synergistic inhibition 
between the carbapenem drug and eDta was tentatively assumed for the metallo-beta 
lactamase producer. the minimum inhibitory concentration (MIC) for meropenem and 
colistin was determined using an Etest strip (HiMedia, India). For phenotypic identification 
of eSBL producers the combination disc method was used (aNDreWS, 2012) with 
cefotaxime, ceftazidime, with and without clavulanic acid. the triple eSBL, eSBL 
& ampC detection ezy MIC Strip (#cat eM079, eM081; hiMedia, India) was used to 
phenotypically confirm the extended spectrum and class C beta-lactamase production. The 
minimum inhibitory concentration (MIC) of cefotaxime, cefepime, ceftazidime, imipenem, 
meropenem, ertapenem and colistin was determined by estrips (hiMedia, India).
Molecular detection of antimicrobial resistance and virulence genes. the genomic 
DNa was extracted by QIaamp DNa Mini kit (Qiagen, India). all the PCr reactions were 
carried out in 96 well thermal cyclers (MJ research PtC-200, Peltier thermal Cycler, 
USa). the details of primers and PCr conditions used for major carbapenemase genes, 
eSBL producing genes, ampC and virulence genes for Shiga toxin producing E. coli 
(SteC; Stx1 and Stx2), enteropathogenic E. coli (ePeC: eaea), enterohemolysin (hlya) 
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are listed in Table 1. The amplified products were visualized by a gel documentation 
system (UVP, Uk) after electrophoresis in 1.5% (w/v) agarose gel containing ethidium 
bromide (0.5 µg/mL, Loba Chemie, India).
Cloning and sequencing. Amplified positive PCR products were purified using 
a gel purification kit (Qiagen, India) and cloned in a p-Drive cloning vector (Qiagen, 
India). the plasmids containing the expected insert were sequenced using commercial 
sequencing services (Eurofins Ltd, Bangalore) for further purification and sequencing by 
the Sanger dideoxy method. after sequencing, homology searches were made using the 
BLaSt algorithm available at http://blast.ncbi.nlm.nih. gov/Blast.cgi.
Results 
The bacteriological analysis of scrotal fluid yielded an E. coli isolate and on 
phenotypic antimicrobial screening the isolate was found to be extensively drug resistant, 
of extended spectrum, class C and a metallo betalactamase (MBL) producer. the isolate 
was resistant to all the antimicrobial agents screened except tigecycline. the MIC of the 
different antibiotics are given in table 2.
table 2. Minimum inhibitory concentration, virulence and antibiotic resistance markers  
of E. coli isolate
Isolate








numberCtX CPM CaZ IMP MrP etP CL
7897P









(CtX-cefotaxime; CPM- cefepime; CaZ-ceftazidime; IMP-imipenem; MrP- meropenem; etP-ertapenem; 
CL-colistin)
On phenotypic MBL screening, the isolate showed a keyhole reaction between eDta 
and meropenem. On MBL estrip the ratio between meropenem MIC and meropenem 
with eDta MIC was more than 8, which indicated the isolate as a potential MBL 
producer. the meropenem MIC of the isolate was more than 256 µg/mL and meropenem 
with eDta MIC was 64 µg/mL. the combined disc method showed the difference in 
zone of inhibition between cefotaxime, ceftazidime, with and without clavulanic acid, 
was more than 8 mm, indicating eSBL producing E. coli. the eSBL & ampC detection 
ezy MIC Strip showed the ratio between MIX+ (ceftazidime, cefotaxime & cefepime 
with clavulanic acid) and MIX- (ceftazidime, cefotaxime & cefepime) was more than 8, 
indicating the isolate as a potential eSBL and ampC producer.
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Molecular detection and sequence analysis revealed the isolate was positive for beta-
lactamase genes blateM (accession No: kX158451) blaCtX-M, blaampC (accession 
No: kX158450), the carbapenemases gene blaNDM1 (accession No: kX090926) and 
the gene for sulphonamide resistance sul1. On blast analysis (http://blast.ncbi.nlm.nih.
gov/Blast.cgi) the dog E. coli isolate blateM, blaampC and blaNDM1 sequences had 
100 per cent homology with blateM, blaampc, blaNDM1 sequences of bacterial isolates 
from humans and food animals. 
Discussion
In general, eSBL producing and carbapenem resistant bacteria screening is limited 
to humans and the hospital environment, although recent reports suggest the emergence 
of such resistant pathogens in livestock, and companion and food animals (Ghatak et 
al., 2013; PrUthVIShree et al., 2017). there is an urgent need for routine screening 
for extended spectrum beta-lactamase producing and carbapenemase resistant bacteria 
in animals, since these mechanisms of resistance are transferable and are of public 
health significance. The companion animals’ role has become more similar to that of 
family members, and they share intimate contact with their owners, which can result in 
transmission cycles of multi‐drug resistant bacteria, as it is known that the microbiota of 
pets and their owners can be very similar (JOhNSON et al., 2008; eWerS et al., 2011; 
SONG et al., 2013; WaLther et al., 2012).
StOLLe et al. (2013) studied carbapenemase producing Escherichia coli in dogs 
harbouring blaCtXM-1, blaOXa-2 and blaTEM-1 genes. YOUSFI et al. (2015) reported 
NDM-5 producing E. coli in a three-year-old German shepherd dog. haraDa et al. 
(2012) screened fecal samples of apparently healthy pups below two months of age from 
Japanese kennels, with no history of antimicrobial use, and they were found to harbor 
MDr E. coli isolates, including eSBL producers. the transmission of MDr pathogenic 
E. coli between companion animals and humans has been documented by a few studies 
(eWerS et al., 2010; PLateLL, et al. 2011).
rZeWUSka et al. (2015) studied the frequency of MDr E. coli in dogs and cats 
in Poland and the prevalence of MDr was 66.8% in the isolates studied. Cats and dogs 
represent potential sources of the spread of antimicrobial resistance, due to the extensive 
use of antimicrobial agents in these animals and their close contact with humans, and 
some studies indicate a possible association between antimicrobial use and the emergence 
of antimicrobial resistance in pets (GUarDaBaSSI et al., 2004). In the present study, the 
SetC harboured blaCtXM, blateM, blaampC, blaNDM and sul1 genes. BOerLIN et 
al. (2005) observed a high correlation of antimicrobial resistance and virulence genes of 
E. coli isolates from swine. 
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the emergence of XDr, carbapenem resistant and eSBL producing E. coli reflects 
the abundant use of broad-spectrum antimicrobials in veterinary care and human 
health. household pets can be reservoirs of bacterial species and resistance genes of 
clinical importance in humans (SaNCheZ et al., 2002; GUarDaBaSSI et al., 2004). 
Carbapenem antibiotics are not licensed for veterinary use anywhere in world but, in 
contrast, the usage of carbapenems is increasing in humans (aShIrU-OreDOPe et 
al., 2012). the presence of carbapenem resistant E. coli in the dog of the present study 
might be from humans or the contaminated environment. Carbapenem resistant, eSBL 
producing and MDr E. coli in companion animals is an important cause of concern in 
human medicine due to the fact that carbapenems are vital for the effective therapy of 
community-acquired and healthcare-associated infections caused by eSBL producing 
bacteria. resistance to this class of antibiotic compromises the therapeutic options for 
patients by leaving only a few or in some cases no other antimicrobials available for 
effective treatment. To the best of our knowledge, this is the first report of blaNDM1 
isolated from a dog in India. 
Conclusion
the isolation of extensively drug resistant, extended spectrum, class C beta-
lactamases and blaNDM-1 carbapenemase producing E. coli from a dog is of great public 
health concern and there is a great possibility of spread of these genes to other pathogens. 
therefore preventive measures are needed to combat the rise of antimicrobial resistant 
pathogens in human and animal populations. 
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Sažetak 
U radu se izvješćuje o molekularnoj karakterizaciji bakterije E. coli izdvojene iz skrotalne tekućine psa, 
iznimno otporne na antibiotike širokog spektra, koja proizvodi klasu C beta-laktamaza i NDM-1 karbapenemazu. 
Pas je bio u dobi od od tri godine. Izolat E. coli bio je osjetljiv samo na tigeciklin, a otporan na sve antibiotike 
primjenjivane u kliničkoj praksi. Minimalna inhibicijska koncentracija (MIC) za meropenem iznosila je 256, 
cefotaksim 128 i cefepim 64 µg/mL. Pretragom genotipa lančanom reakcijom polimerazom izolat je bio 
pozitivan na gene blaNDM, blaCtX-M, blaampC, blateM i sul1. Proizvodio je eSBL, ampC i metalo-beta-
laktamazu. Molekularnom patotipizacijom dokazano je da posjeduje gen za shiga-toksin (Stx2). E. coli otporna 
na karbapenem, koja proizvodi beta-laktamaze širokog spektra, velika je prijetnja za javno zdravstvo s obzirom 
na to da postoji velika mogućnost prijenosa E. coli s genom za rezistenciju na ljude u bliskom dodiru s kućnim 
ljubimcima. Ovo je prvo izvješće o blaNDM1 dokazanom u psa u Indiji. 
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